Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in pseudomyxoma peritonei

European Journal of Surgical Oncology

Volumn 38, Issue 10, 2012, Pages 969-976

  SOrensen O ^a,c   Flatmark, K ^a   Reed, W ^b   Wiig, J N ^a   Dueland, S ^a   Giercksky, K E ^a,c   Larsen, S G ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Cytoreductive surgery; EPIC; HIPEC; Mitomycin C; Pseudomyxoma peritonei

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CELL DIFFERENTIATION; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PERITONEUM CANCER; PERITONEUM PSEUDOMYXOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, PARENTERAL; LAPAROTOMY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NORWAY; PERIOPERATIVE CARE; PERITONEAL NEOPLASMS; PERITONEUM; PROPORTIONAL HAZARDS MODELS; PSEUDOMYXOMA PERITONEI; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866418580     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.06.552     Document Type: Article

References (23)

1. P.H. Sugarbaker Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon Ann Surg 219 1994 109 111
2. P.H. Sugarbaker Peritoneum as the first-line of defense in carcinomatosis J Surg Oncol 95 2007 93 96
3. T.J. Miner, J. Shia, D.P. Jaques, D.S. Klimstra, M.F. Brennan, and D.G. Coit Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy Ann Surg 241 2005 300 308
4. D.B. Gough, J.H. Donohue, and A.J. Schutt Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach Ann Surg 219 1994 112 119
5. P.H. Sugarbaker Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome Eur J Surg Oncol 27 2001 239 243
6. H. Youssef, C. Newman, K. Chandrakumaran, F. Mohamed, T.D. Cecil, and B.J. Moran Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin Dis Colon Rectum 54 2011 293 299
7. T.D. Yan, L. Bijelic, and P.H. Sugarbaker Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms Ann Surg Oncol 14 2007 2289 2299
8. P.H. Sugarbaker Epithelial appendiceal neoplasms Cancer J 15 2009 225 235
9. R. Hadi, V. Saunders, and O. Utkina Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy ANZ J Surg 76 2006 156 161
10. P.H. Sugarbaker Peritonectomy procedures Cancer Treat Res 82 1996 235 253
11. A.D. Stephens, R. Alderman, and D. Chang Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique Ann Surg Oncol 6 1999 790 796
12. L. Benoit, N. Cheynel, P. Ortega-Deballon, G.D. Giacomo, B. Chauffert, and P. Rat Closed hyperthermic intraperitoneal chemotherapy with open abdomen: a novel technique to reduce exposure of the surgical team to chemotherapy drugs Ann Surg Oncol 15 2008 542 546
13. S. van Ruth, V.J. Verwaal, and F.A. Zoetmulder Pharmacokinetics of intraperitoneal mitomycin C Surg Oncol Clin N Am 12 2003 771 780
14. B.M. Ronnett, C.M. Zahn, R.J. Kurman, M.E. Kass, P.H. Sugarbaker, and B.M. Shmookler Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei" Am J Surg Pathol 19 1995 1390 1408
15. O. Glehen, F. Mohamed, and P.H. Sugarbaker Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy Ann Surg 240 2004 278 285
16. D. Elias, E. Benizri, D. Di Pietrantonio, P. Menegon, D. Malka, and B. Raynard Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis Ann Surg Oncol 14 2007 509 514
17. Y.L. Klaver, T. Hendriks, R.M. Lomme, H.J. Rutten, R.P. Bleichrodt, and I.H. de Hingh Intraoperative versus early postoperative intraperitoneal chemotherapy after cytoreduction for colorectal peritoneal carcinomatosis: an experimental study Ann Surg Oncol 2011
18. B.J. Moran Decision-making and technical factors account for the learning curve in complex surgery J Public Health (Oxf) 28 2006 375 378
19. D. Baratti, S. Kusamura, and D. Nonaka Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (Hipec) Ann Surg Oncol 15 2008 526 534
20. T.C. Chua, T.D. Yan, and M.E. Smigielski Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution Ann Surg Oncol 16 2009 1903 1911
21. R.M. Smeenk, V.J. Verwaal, N. Antonini, and F.A. Zoetmulder Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg 245 2007 104 109
22. P.H. Sugarbaker Successful management of microscopic residual disease in large bowel cancer Cancer Chemother Pharmacol 43 Suppl. 1999 S15 S25
23. T.C. Chua, A. Al-Zahrani, and A. Saxena Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Ann Surg Oncol 18 2011 1582 1589